Table 2.
The prognostic characteristics of advanced gastric cancer patients
| Characteristics | Univariate
|
Multivariate
|
||||
|---|---|---|---|---|---|---|
| n | MS (months) | P-value | HR | 95% CI | P-value | |
| Age (years) | 0.624 | |||||
| ≥60 | 190 | 21.13 | ||||
| <60 | 84 | 22.33 | ||||
| Sex | 0.632 | |||||
| Male | 192 | 19.27 | ||||
| Female | 82 | 26.80 | ||||
| Tumor site | 0.136 | |||||
| Gastric cardia | 72 | 20.17 | ||||
| Gastric body | 130 | 22.52 | ||||
| Gastric antrum | 72 | 10.38 | ||||
| Tumor size (cm) | 0.370 | |||||
| ≥5.0 | 192 | 20.52 | ||||
| <5 | 82 | 22.40 | ||||
| Differentiation | 0.502 | |||||
| Well/moderate | 155 | 22.87 | ||||
| Poor | 119 | 21.13 | ||||
| Clinic stage | 0.000 | 2.201 | 1.605–3.020 | 0.000 | ||
| III | 185 | 26.43 | ||||
| IV | 89 | 14.27 | ||||
| Surgical procedure | 0.001 | 0.548 | 0.403–0.745 | 0.000 | ||
| Radical | 119 | 29.70 | ||||
| Palliative | 155 | 18.07 | ||||
| Immunotherapy | 0.036 | 0.641 | 0.450–0.913 | 0.014 | ||
| Yes | 71 | 29.70 | ||||
| No | 203 | 19.90 | ||||
Abbreviations: CI, confidence interval; HR, hazard ratio; MS, median survival.